XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2

Revenue Recognition and Collaborative Arrangements (Tables)

6 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Schedule of net revenue from collaborative arrangements

Net revenue recognized under our GSK Agreements was as follows:

		Three Months Ended June 30,								Six Months Ended June 30,
(In thousands)		2022				2021				2022				2021
Royalties from a related party    - RELVAR/BREO		$	59,326			$	65,916			$	115,090			$	122,306
Royalties from a related party    - ANORO			9,630				11,960				18,072				22,460
Royalties from a related party    - TRELEGY			42,720				26,386				72,029				48,470
Total royalties from a related party			111,676				104,262				205,191				193,236
Less: amortization of capitalized fees    paid to a related party			(3,456	)			(3,456	)			(6,912	)			(6,912	)
Royalty revenue from GSK		$	108,220			$	100,806			$	198,279			$	186,324

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration